Literature DB >> 35037091

Arrhythmias Requiring ECMO in Infants Without Structural Congenital Heart Disease.

Andrew Well1,2, Arnold Fenrich3,4, Daniel Shmorhun3,4, Daniel Stromberg3,4, Preston Lavinghousez3,4, Ziv Beckerman3,5, Charles D Fraser3,5, Carlos M Mery3,5.   

Abstract

Arrhythmias account for 55 per 100,000 patient evaluations in pediatric emergency departments. Most arrhythmias in children are amenable to medical management or cardioversion. Rarely, arrhythmias lead to significant hemodynamic instability requiring extracorporeal membrane oxygenation (ECMO) support. This study seeks to evaluate children under 1 year of age with a structurally normal heart requiring ECMO for an arrhythmia. This is a retrospective review of the Extracorporeal Life Support Organization Registry. All patients less than 1 year of age between 2009 and 2019 with a diagnosis of arrhythmia and without a diagnosis of structural heart malformation were included. Demographics, clinical characteristics, and outcomes were assessed with descriptive statistics and univariate and multivariable analyses. A total of 140 eligible patients were identified from the dataset. The most common arrhythmia was supraventricular tachycardia (SVT) in 70 (50%) patients. ECMO complications occurred in 106 (76.3%) patients and survival to discharge was achieved in 120 (85.7%) patients. In-hospital mortality was associated with neuromuscular blockade prior to ECMO [aOR 10.0 (95% CI 2.95-41.56), p < 0.001], neurologic ECMO complication [aOR 28.1 (95% CI 6.6-155.1), p < 0.001], and race with white race being protective [aOR 0.13, (95% CI 0.02-0.21), p = 0.002]. Similar survival and complication rates were found in subgroup analysis of SVT arrhythmias alone. Arrhythmias necessitating ECMO support in infants without structural congenital heart disease is a rare occurrence. However, survival to hospital discharge is favorable at greater than 85%. Given the favorable survival, earlier and more aggressive utilization of ECMO may result in improved outcomes.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Arrhythmias; Extracorporeal Life Support Organization Registry; Extracorporeal membrane oxygenation; Outcomes

Mesh:

Year:  2022        PMID: 35037091     DOI: 10.1007/s00246-021-02803-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  Extracorporeal membrane oxygenation support for intractable primary arrhythmias and complete congenital heart block in newborns and infants: short-term and medium-term outcomes.

Authors:  Umesh Dyamenahalli; Volkan Tuzcu; Eudice Fontenot; John Papagiannis; R D B Jaquiss; Adnan Bhutta; William R Morrow; Christopher C Erickson; Michiaki Imamura; Parthak Prodhan
Journal:  Pediatr Crit Care Med       Date:  2012-01       Impact factor: 3.624

2.  Adenosine in the management of supraventricular tachycardia in children.

Authors:  M C Sherwood; K C Lau; G F Sholler
Journal:  J Paediatr Child Health       Date:  1998-02       Impact factor: 1.954

3.  Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children.

Authors:  J Till; E A Shinebourne; M L Rigby; B Clarke; D E Ward; E Rowland
Journal:  Br Heart J       Date:  1989-09

4.  Acute Management of Refractory and Unstable Pediatric Supraventricular Tachycardia.

Authors:  Jonathan Lewis; Gaurav Arora; Dana L Tudorascu; Robert W Hickey; Richard A Saladino; Mioara D Manole
Journal:  J Pediatr       Date:  2016-11-29       Impact factor: 4.406

5.  Emergency diagnosis and management of pediatric arrhythmias.

Authors:  Carla R Hanash; Jane E Crosson
Journal:  J Emerg Trauma Shock       Date:  2010-07

6.  Use of adenosine for diagnosis and treatment of tachyarrhythmias in pediatric patients.

Authors:  M A Ralston; T K Knilans; D W Hannon; S R Daniels
Journal:  J Pediatr       Date:  1994-01       Impact factor: 4.406

7.  Cardiovascular collapse during amiodarone infusion in a hemodynamically compromised child with refractory supraventricular tachycardia.

Authors:  Sunil Saharan; Seshadri Balaji
Journal:  Ann Pediatr Cardiol       Date:  2015 Jan-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.